All lobbying filings

Ferox Strategies

Ferox Strategies filed a Q1 report for Fresenius Kabi USA LLC on April 17, 2026, reporting $50,000 in lobbying income.

Lobbying for Fresenius Kabi USA LLC · Generic and biosimilar pharmaceutical manufacturer

As filed: FEROX STRATEGIES for FRESENIUS KABI USA LLC.

All filings by Ferox Strategies · Everything Fresenius Kabi USA LLC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Lobbyists on this filing 1

DEBRA DIXON New on this filing

Previously held: Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

General healthcare issues related to biosimilar industries.

Pharmacy

General patent issues related to biosimilar industries.

Trade (domestic/foreign)

General issues related to trade.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.